<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02475928</url>
  </required_header>
  <id_info>
    <org_study_id>Cirrhosis01</org_study_id>
    <nct_id>NCT02475928</nct_id>
  </id_info>
  <brief_title>Zinc Supplementation in Cirrhotic Patients</brief_title>
  <acronym>ZnDCP</acronym>
  <official_title>Zinc Supplementation as Treatment of Dysgeusias in Cirrhotic Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fundación Clínica Médica Sur</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fundación Clínica Médica Sur</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the effect of zinc supplementation in the treatment
      for dysgeusia, progression disease and quality of life in patients with liver cirrhosis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Taste disorders are symptomatologies in patients with cirrhosis, these have a direct effect
      in modification of food consumption, increasing weight loss, anorexia and malnutrition, which
      impacts in decompensation rates and mortality.

      It has been proposed that zinc deficiency is one of the causes for development of taste
      disorders. The aim of this study is to describe the presence of taste disorders in patients
      with cirrhosis and evaluate the effect of zinc supplementation in treatment of taste
      disorders, and in progression of chronic liver disease.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>April 2015</start_date>
  <completion_date type="Anticipated">December 2016</completion_date>
  <primary_completion_date type="Anticipated">December 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Dysgeusia</measure>
    <time_frame>Presence of any taste disorder at 6 months</time_frame>
    <description>Evaluation of presence of any taste disorder, according to questionnaires and evaluation of perception and recognition thresholds with ascending molar concentrations of basic tastes.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">70</enrollment>
  <condition>Dysgeusia</condition>
  <condition>Liver Cirrhosis</condition>
  <arm_group>
    <arm_group_label>100 mg placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>100 mg Placebo plus nutritional education</description>
  </arm_group>
  <arm_group>
    <arm_group_label>100 mg zinc supplement</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Nutritional education plus 100 mg of zinc gluconate</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>zinc gluconate</intervention_name>
    <description>Zinc supplementation plus nutritional education</description>
    <arm_group_label>100 mg zinc supplement</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <arm_group_label>100 mg placebo</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Nutritional education</intervention_name>
    <arm_group_label>100 mg placebo</arm_group_label>
    <arm_group_label>100 mg zinc supplement</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Cirrhotic patients by any etiology, with any dysgeusia

        Exclusion Criteria:

          -  Patients with hepatic encephalopathy at the time of dysgeusia evaluation

          -  Patients with any neurological disease

          -  Patients with respiratory diseases ath the time of dysgeusia evaluation

          -  Patients with active alcohol consumption
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Norberto C Chávez-Tapia, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medica Sur Clinic &amp; Foundation</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Eva Juárez-Hernández</last_name>
    <role>Study Director</role>
    <affiliation>Medica Sur Clinic &amp; Foundation</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Norberto C Chávez-Tapia, PhD</last_name>
    <phone>54246850</phone>
    <email>nchavezt@medicasur.org.mx</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Eva Juárez-Hernández</last_name>
    <phone>54246850</phone>
    <email>evajuarezh@hotmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Medica Sur Clinic &amp; Foundation</name>
      <address>
        <city>Mexico City</city>
        <zip>14050</zip>
        <country>Mexico</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Varenka J Barbero-Becerra, PhD</last_name>
      <phone>54247200</phone>
      <email>vbarberob@medicasur.org.mx</email>
    </contact>
  </location>
  <location_countries>
    <country>Mexico</country>
  </location_countries>
  <verification_date>May 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 29, 2015</study_first_submitted>
  <study_first_submitted_qc>June 16, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 19, 2015</study_first_posted>
  <last_update_submitted>June 16, 2015</last_update_submitted>
  <last_update_submitted_qc>June 16, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 19, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Fundación Clínica Médica Sur</investigator_affiliation>
    <investigator_full_name>Norberto Carlos Chavez Taia</investigator_full_name>
    <investigator_title>Obesity and Digestive Diseases Unit Chief</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Liver Cirrhosis</mesh_term>
    <mesh_term>Dysgeusia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Zinc</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

